Exactech Gets Sweetened $737M Cash Deal From TPG Capital

The revised offer of $49.25 per share represents an increase of 17.3 percent to the previously announced $42 per share, the company said.

Dec 4 (Reuters) - Medical device maker Exactech said on Monday private equity firm TPG Capital had raised its offer to $737 million in cash.

The revised offer of $49.25 per share represents an increase of 17.3 percent to the previously announced $42 per share, the company said.

Exactech’s board has approved the amended terms and said the deal is in the best interests of shareholders.

MORE ON THIS TOPIC